(2S,5S)-1-((S)-2-METHOXYCARBONYLAMINO)-3-METHYLBUTYRYL)-5-METHYLPYRROLIDINE-2-CARBOXYLIC ACIDpyrrolidine-2-carboxylic acid | CAS:1335316-40-9

We serve (2S,5S)-1-((S)-2-METHOXYCARBONYLAMINO)-3-METHYLBUTYRYL)-5-METHYLPYRROLIDINE-2-CARBOXYLIC ACIDpyrrolidine-2-carboxylic acid CAS:1335316-40-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 (2S,5S)-1-((S)-2-METHOXYCARBONYLAMINO)-3-METHYLBUTYRYL)-5-METHYLPYRROLIDINE-2-CARBOXYLIC ACIDpyrrolidine-2-carboxylic acid

Chemical Name:  (2S,5S)-1-((S)-2-METHOXYCARBONYLAMINO)-3-METHYLBUTYRYL)-5-METHYLPYRROLIDINE-2-CARBOXYLIC ACIDpyrrolidine-2-carboxylic acid
CAS.NO:   1335316-40-9
Synonyms:
methylpyrrolidine-2-carboxylic acid
(2S,5S)-1-((S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid
(5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline
Velpatasvir Intermediate 2

Molecular Formula:  C13H22N2O5
Molecular Weight: 286.32400

Physical and Chemical Properties:
Density: 1.2±0.1 g/cm3
Boiling point: 489.9±40.0 °C at 760 mmHg
Melting point: /
Flash point: 250.1±27.3 °C
Refractive index:1.502

Specification:
Appearance:  White  powder
Purity:≥99.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Intermediates of Velpatasvir CAS:1377049-84-7.



Contact us for information like (2S,5S)-1-((S)-2-METHOXYCARBONYLAMINO)-3-METHYLBUTYRYL)-5-METHYLPYRROLIDINE-2-CARBOXYLIC ACIDpyrrolidine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Velpatasvir Intermediate 2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Velpatasvir Intermediate 2 Use and application,Velpatasvir Intermediate 2 technical grade,usp/ep/jp grade.


Related News: In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.5-Bromo-2-fluorobenzoic acid manufacturer Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.2-Chloro-4-(Methylsulfonyl)Benzoic Acid supplier Australia has started denying entry to all travelers who have come from or transited through mainland China.1-Benzylpiperazine dihydrochloride vendor Australia has started denying entry to all travelers who have come from or transited through mainland China.From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.